While COVID-19 brought with it a heightened level of uncertainty in the broader IT consulting sector, the M&A marketplace remains red hot with equity firms doubling down on the Federal sector. Here we note the announced acquisition of two longtime partners to the Food and Drug Administration, to include one of the original FDA ELMS Prime IDIQ awardees.
The post Two CIO-SP3 SB and 8(a) STARS II Primes, one a Major FDA and HHS Partner, are acquired appeared first on G2Xchange Health.
